Company Update

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC  20549 ________________ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 20, 2019 ( September 19, 2019 ) COLGATE PALMOLIVE COMPANY  (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 300 Park Avenue , New York , New York 10022 (Address of Principal Executive Offices) (Zip Code) Registrant’s telephone number, including area code ( 212 ) 310-2000 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $1.00 par value   CL   New York Stock Exchange 0.500% Notes due 2026   CL 26   New York Stock Exchange 1.375% Notes due 2034   CL 34   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 8.01. Other Events.   On September 19, 2019, Colgate-Palmolive Company (“ Colgate ”) completed its previously announced acquisition of Laboratoires Filorga Cosmétiques, pursuant to a Share Purchase Agreement, dated as of July 11, 2019, by and between Colgate and Filorga Initiatives, for a cash purchase price of approximately €1,516 million (approximately US$ 1,674 million), which includes interest on the previously disclosed equity purchase price. SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.     COLGATE-PALMOLIVE COMPANY                           By: /s/ Jennifer M. Daniels   Name: Jennifer M. Daniels   Title: Chief Legal Officer and Secretary Date:  September 20, 2019